imiquimod has been researched along with Disease Exacerbation in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.63) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 23 (60.53) | 24.3611 |
| 2020's | 7 (18.42) | 2.80 |
| Authors | Studies |
|---|---|
| Abram, CL; Bevilacqua, D; Cassatella, MA; Caveggion, E; Cestari, T; Constantin, G; Costa, S; De Sanctis, F; Donini, M; Dusi, S; Gasperini, S; Girolomoni, G; Lonardi, S; Lowell, CA; Pettinella, F; Rodegher, P; Scapini, P; Tagliaro, F; Ugel, S; Vermi, W; Zenaro, E | 1 |
| Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
| Becker, L; Berking, C; French, LE; Heppt, MV; Kohl, C; Steeb, T | 1 |
| Linares-Gonzalez, L; Navarro-Triviño, FJ; Ródenas-Herranz, T; Ruiz-Villaverde, R | 1 |
| Conforti, C; Corneli, P; di Meo, N; Dianzani, C; Farinazzo, E; Giuffrida, R; Magaton Rizzi, G; Moret, A; Zalaudek, I | 1 |
| Dika, E; Lambertini, M; Melotti, B; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G | 1 |
| Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
| Cai, S; Chen, H; Chen, L; Dong, L; Gong, F; Li, B; Li, J; Mao, J; Qian, Y; Shi, J; Tan, Z; Xiao, Y; Xu, Y; Zeng, F; Zheng, F | 1 |
| Bu, DF; Cao, CX; Dang, NN; Han, YF; Jiang, ZX; Liu, FT; Man, XY; Meng, Z; Shi, ZR; Tan, GZ; Wang, L; Wei, KH; Zhang, YP | 1 |
| Fukushige, T; Hashiguchi, T; Higashi, Y; Ibusuki, A; Kanekura, T; Yamakuchi, M | 1 |
| Chen, H; Duan, X; Gan, L; Jaypaul, H; Liu, N; Liu, X; Makamure, JT; Ming, Z; Wang, X; Zhang, S; Zhu, K | 1 |
| Que, SKT; Schmults, CD; Zwald, FO | 1 |
| Baraldi, C; Dika, E; Fanti, PA; Guglielmo, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G | 1 |
| Brand, A; Clausen, BE; Daiber, A; Karbach, S; Klebow, S; Kolbinger, F; Kossmann, S; Münzel, T; Roohani, S; Schüler, R; Ullmann, E; Veras, FP; Waisman, A; Wenzel, P; Wild, J; Wohn, C | 1 |
| Aoki, R; Arai, MM; Harada, Y; Hisamatsu, T; Kanai, T; Kiyohara, H; Koda, Y; Mikami, Y; Miyamoto, K; Mizuno, S; Naganuma, M; Nomura, E; Sujino, T; Teratani, T | 1 |
| Kircik, LH | 1 |
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Bahoric, B; Basik, M; Batist, G; Guay, MP; Henriques, L; Kavan, P; Palumbo, M | 1 |
| Bourgault-Villada, I; Clerici, T; Elfatoiki, FZ; Longvert, C; Roudier-Pujol, C; Saiag, P; Vasseur, E | 1 |
| Choi, EJ; Hong, MP; Kie, JH; Kim, HR; Lee, A; Lee, HK; Lim, W; Moon, BI; Seoh, JY | 1 |
| Amberg, N; Brunner, PM; Drobits, B; Glitzner, E; Holcmann, M; Kopp, T; Korosec, A; Schonthaler, HB; Sibilia, M; Stingl, G; Wagner, EF | 1 |
| Khaiboullina, SF; Lombardi, VC; Rizvanov, AA | 1 |
| den Hollander, JC; van der Ende, ME; van der Snoek, EM | 1 |
| Chen, X; Huo, R; Li, H; Li, N; Shen, B; Shen, Z; Sun, Y; Wang, B; Wu, P; Zhai, T; Zhang, J; Zhou, Z | 1 |
| Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
| Basset-Séguin, N; Del Marmol, V; Dirschka, T; Dummer, R; Gupta, G; Jemec, GBE; Malvehy, J; Micali, G; Pellacani, G; Peris, K; Puig, S; Stockfleth, E; Stratigos, AJ; Zalaudek, I | 1 |
| Hoekzema, R; Jansma, EP; Prinsen, CAC; Tio, D; van der Woude, J; van Montfrans, C | 1 |
| Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M | 1 |
| Aires, D; Dusing, R; Meggison, A; Miller, AK | 1 |
| Botella-Estrada, R; Nagore, E | 1 |
| Arlette, JP; Trotter, MJ | 1 |
| Grossman, L; Mena, J; Miller, RL; Shi, Y; Sorrenti, V; Spaner, DE | 1 |
| Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W | 1 |
| Altmeyer, P; Markus, S; Oster-Schmidt, C | 1 |
| Fargnoli, MC; Micantonio, T; Peris, K | 1 |
| Goh, MS | 1 |
| Cox, NH; Eedy, DJ; Morton, CA | 1 |
| Buckley, R; Smith, K | 1 |
12 review(s) available for imiquimod and Disease Exacerbation
| Article | Year |
|---|---|
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Successful treatment of micaceous balanitis with 5% topical imiquimod: case report and review of the literature.
Topics: Administration, Topical; Adult; Balanitis; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Male; Penile Neoplasms; Precancerous Conditions; Treatment Outcome | 2020 |
Current therapies for actinic keratosis.
Topics: Aftercare; Carcinoma, Squamous Cell; Chemexfoliation; Cryotherapy; Curettage; Dermoscopy; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Practice Guidelines as Topic; Protective Clothing; Skin; Skin Neoplasms; Sunlight; Sunscreening Agents | 2020 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
Plasmacytoid dendritic cells, a role in neoplastic prevention and progression.
Topics: Adjuvants, Immunologic; Aminoquinolines; Cancer Vaccines; Dendritic Cells; Disease Progression; Humans; Imiquimod; Immunotherapy; Melanoma; Neoplasms; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptors; Tumor Escape; Tumor Microenvironment | 2015 |
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2016 |
Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.
Topics: Algorithms; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Disease Progression; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy | 2017 |
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Skin Neoplasms | 2017 |
[Imiquimod in the treatment of lentigo maligna].
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Contraindications; Cryotherapy; Disease Progression; Drug Approval; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Microscopy, Confocal; Mohs Surgery; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome | 2011 |
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays | 2004 |
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays | 2003 |
Guidelines for management of Bowen's disease: 2006 update.
Topics: Adjuvants, Immunologic; Aminoquinolines; Bowen's Disease; Cautery; Cryotherapy; Curettage; Disease Progression; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Laser Therapy; Photochemotherapy; Risk Factors; Skin Neoplasms | 2007 |
1 trial(s) available for imiquimod and Disease Exacerbation
| Article | Year |
|---|---|
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms | 2011 |
25 other study(ies) available for imiquimod and Disease Exacerbation
| Article | Year |
|---|---|
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis.
Topics: Animals; Disease Models, Animal; Disease Progression; Eczema; Imiquimod; Mice; NADP; NADPH Oxidases; Neutrophils; Psoriasis | 2022 |
Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.
Topics: Adjuvants, Immunologic; Disease Progression; Diterpenes; Europe; Humans; Imiquimod; Keratosis, Actinic; Meta-Analysis as Topic; Network Meta-Analysis; Photochemotherapy; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2019 |
In transit melanoma and imiquimod: A case of disease progression.
Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Melanoma; Skin Neoplasms | 2020 |
An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis.
Topics: Adult; Animals; Autocrine Communication; Biopsy; Case-Control Studies; Disease Models, Animal; Disease Progression; Healthy Volunteers; Humans; Imiquimod; Injections, Intradermal; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Keratinocytes; Male; Mice; Middle Aged; Psoriasis; Recombinant Proteins; Severity of Illness Index; Signal Transduction; Skin; Transcriptional Activation; Up-Regulation | 2021 |
Decrease of galectin-3 in keratinocytes: A potential diagnostic marker and a critical contributor to the pathogenesis of psoriasis.
Topics: Animals; Biomarkers; Cells, Cultured; Disease Models, Animal; Disease Progression; Galectin 3; Humans; Imiquimod; Inflammation; Keratinocytes; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Phenylurea Compounds; Psoriasis; Receptors, Interleukin-8B; Signal Transduction; Skin | 2018 |
High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
Topics: Animals; Body Weight; Cholesterol; Cytokines; Dermatitis; Diet, High-Fat; Disease Models, Animal; Disease Progression; Hyperlipidemias; Imiquimod; Inflammasomes; Inflammation; Male; Mice; Mice, Inbred C57BL; Neutrophils; Psoriasis; Skin | 2018 |
Ten-eleven Translocation-2 Regulates DNA Hydroxymethylation Status and Psoriasiform Dermatitis Progression in Mice.
Topics: 5-Methylcytosine; Aminoquinolines; Animals; Case-Control Studies; Cell Differentiation; Cell Proliferation; Chemokine CXCL1; Dioxygenases; Disease Models, Animal; Disease Progression; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Female; Humans; Imiquimod; Interferon-gamma; Interleukin-17; Mice, Inbred BALB C; Proto-Oncogene Proteins; Psoriasis; Skin; Time Factors | 2018 |
Reply to: "Cutaneous squamous cell carcinoma progression during imiquimod treatment".
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms | 2018 |
Cutaneous squamous cell carcinoma progression during imiquimod treatment.
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms | 2018 |
Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis.
Topics: Animals; Antibodies, Blocking; Aorta; Disease Models, Animal; Disease Progression; Humans; Imiquimod; Immunotherapy; Inflammation; Interleukin-17; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Oxidative Stress; Psoriasis; Reactive Oxygen Species; Skin; Vascular Diseases | 2019 |
Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Topics: Animals; B-Lymphocytes; Cell Movement; Colitis; Dermatitis; Dextran Sulfate; Disease Progression; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hematopoietic Stem Cells; Imiquimod; Immunoglobulin D; Immunoglobulin M; Intestines; Lactobacillus; Lymph Nodes; Lymphocyte Depletion; Mice, Inbred C57BL; Permeability; Psoriasis; Toll-Like Receptor 7 | 2019 |
Addressing the Challenges of Treating Actinic Keratosis
Topics: Dermatologic Agents; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy | 2019 |
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting | 2013 |
Imiquimod in the treatment of breast cancer skin metastasis.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Fatal Outcome; Female; Humans; Imiquimod; Pain; Skin Neoplasms; Treatment Outcome | 2014 |
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Electrocoagulation; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Interferon-alpha; Laser Therapy; Lasers, Gas; Leg; Lymphatic Metastasis; Male; Melanoma; Palliative Care; Remission Induction; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2014 |
Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function.
Topics: Acetylcysteine; Aminoquinolines; Animals; Dermatitis; Disease Progression; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hyperbaric Oxygenation; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; NADPH Oxidases; Naphthoquinones; Psoriasis; Reactive Oxygen Species; T-Lymphocytes, Regulatory | 2014 |
Specific roles for dendritic cell subsets during initiation and progression of psoriasis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibodies, Monoclonal; Antigen-Presenting Cells; Bone Marrow Transplantation; Dendritic Cells; Disease Progression; Flow Cytometry; Humans; Imiquimod; Interleukin-10; Interleukin-23; Langerhans Cells; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Proto-Oncogene Proteins c-jun; Psoriasis; Receptors, Interleukin; Signal Transduction; Skin; Transcription Factors | 2014 |
Imiquimod 5% cream for five consecutive days a week in an HIV-infected observational cohort up to 32 weeks in the treatment of high-grade squamous intraepithelial lesions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Disease Progression; Electrocoagulation; Female; HIV Seropositivity; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Prospective Studies; Squamous Intraepithelial Lesions of the Cervix | 2015 |
CCN1, a Pro-Inflammatory Factor, Aggravates Psoriasis Skin Lesions by Promoting Keratinocyte Activation.
Topics: Aminoquinolines; Animals; Biopsy, Needle; Cell Proliferation; Cells, Cultured; Cysteine-Rich Protein 61; Disease Models, Animal; Disease Progression; Extracellular Matrix; Female; Humans; Imiquimod; Immunohistochemistry; Inflammation Mediators; Interleukin-23; Keratinocytes; Mice; Mice, Inbred BALB C; Mice, Knockout; Psoriasis; Random Allocation; Signal Transduction | 2015 |
Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms | 2011 |
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome | 2005 |
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine | 2003 |
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Disease Progression; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms | 2006 |
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome | 2006 |
Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Chronic Disease; Disease Progression; Female; HIV-1; Humans; Imiquimod; Molluscum Contagiosum | 1999 |